Lsl Pharma Group Inc (LSL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 606 | 707 | 471 | 475 | 354 |
| Accounts receivable | -685 | 27 | -279 | 124 | -125 |
| Other Working Capital | -5,508 | 440 | -1,401 | -323 | -526 |
| Other Operating Activity | 1,167 | 313 | 726 | 176 | 210 |
| Operating Cash Flow | $-4,420 | $1,487 | $-483 | $452 | $-87 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -849 | -440 | -374 | -453 | -1,196 |
| Net Acquisitions | 0 | 0 | N/A | -1,120 | -30 |
| Purchase Sale Intangibles | -715 | -545 | -262 | -564 | -167 |
| Investing Cash Flow | $-1,564 | $-985 | $-636 | $-2,137 | $-1,393 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,452 | 5,128 | 1,305 | 785 | -165 |
| Debt Issued | 8,390 | 500 | 598 | 5,844 | 1,755 |
| Debt Repayment | -6,742 | -671 | -540 | -4,032 | -792 |
| Common Stock Issued | 2,275 | 0 | 0 | 0 | 960 |
| Other Financing Activity | -1,007 | -667 | -363 | -780 | -403 |
| Financing Cash Flow | $1,464 | $4,290 | $1,000 | $1,817 | $1,355 |
| Beginning Cash Position | 4,969 | 177 | 296 | 164 | 289 |
| End Cash Position | 449 | 4,969 | 177 | 296 | 164 |
| Net Cash Flow | $-4,520 | $4,792 | $-119 | $132 | $-125 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,420 | 1,487 | -483 | 452 | -87 |
| Capital Expenditure | -1,564 | -985 | -636 | -1,017 | -1,363 |
| Free Cash Flow | -5,984 | 502 | -1,119 | -565 | -1,450 |